GL1X · GenesisL1 explorer

MolNFT v1 · #3636 · protein

Aspects of receptor binding and signalling of interleukin-4 investigated by site-directed mutagenesis and NMR spectroscopy

1CYL: “Aspects of receptor binding and signalling of interleukin-4 investigated by site-directed mutagenesis and NMR…”. Solution nmr, 1 pocket (best druggability 0.35). MolNFT v1 #3636 on GenesisL1: 3D structure, binding sites and pockets…

PDB
1CYL
Type
protein
Length
129 residues
Chains
1
Method
solution nmr
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Interleukin-4
UniProt
P05112
Pockets
1 · best druggability 0.35

Structure

solution nmr · 1 distinct chain · 59% helix, 2% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AInterleukin-4protein12959% helix, 2% strandP05112

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1770.350.7617empty

Modifications

Observed in the structure: 3 disulfide (disulfide).

Compared structures

  • 1CYL · Aspects of receptor binding and signalling of interleukin-4 investigated by site-directed… · the same entry in another collection · chain A against A, TM-score 1.00
  • P05112 · AlphaFold monomer V2.0 prediction for interleukin-4 (P05112) · a predicted model of the same protein · chain A against A, TM-score 0.85

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.